BioVie Statistics
Share Statistics
BioVie has 18.45M
shares outstanding. The number of shares has increased by -69.83%
in one year.
| Shares Outstanding | 18.45M |
| Shares Change (YoY) | -69.83% |
| Shares Change (QoQ) | 3.85% |
| Owned by Institutions (%) | 4.71% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1,476 |
| FTD / Avg. Volume | 0.34% |
Short Selling Information
The latest short interest is 1.07M, so 5.78% of the outstanding
shares have been sold short.
| Short Interest | 1.07M |
| Short % of Shares Out | 5.78% |
| Short % of Float | 6.64% |
| Short Ratio (days to cover) | 11.98 |
Valuation Ratios
The PE ratio is -1.17 and the forward
PE ratio is -0.68.
BioVie's PEG ratio is
0.02.
| PE Ratio | -1.17 |
| Forward PE | -0.68 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 2.43 |
| P/FCF Ratio | -1.35 |
| PEG Ratio | 0.02 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for BioVie.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.57,
with a Debt / Equity ratio of 0.39.
| Current Ratio | 2.57 |
| Quick Ratio | 2.57 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | -0.19 |
| Debt / FCF | -0.22 |
| Interest Coverage | -11.12 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-2,294,323.79 |
| Employee Count | 14 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -77.16% in the
last 52 weeks. The beta is 1.18, so BioVie's
price volatility has been higher than the market average.
| Beta | 1.18 |
| 52-Week Price Change | -77.16% |
| 50-Day Moving Average | 0.99 |
| 200-Day Moving Average | 2.06 |
| Relative Strength Index (RSI) | 56.46 |
| Average Volume (20 Days) | 439,598 |
Income Statement
| Revenue | n/a |
| Gross Profit | -229.38K |
| Operating Income | -32.18M |
| Net Income | -32.12M |
| EBITDA | -31.95M |
| EBIT | -32.18M |
| Earnings Per Share (EPS) | -3.56 |
Full Income StatementBalance Sheet
The company has 23.84M in cash and 6.11M in
debt, giving a net cash position of 17.73M.
| Cash & Cash Equivalents | 23.84M |
| Total Debt | 6.11M |
| Net Cash | 17.73M |
| Retained Earnings | -334.23M |
| Total Assets | 25.69M |
| Working Capital | 23.22M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -27.95M
and capital expenditures 0, giving a free cash flow of -27.95M.
| Operating Cash Flow | -27.95M |
| Capital Expenditures | n/a |
| Free Cash Flow | -27.95M |
| FCF Per Share | -3.09 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
